Treatment history of patients receiving biologic therapy for psoriasis - a Danish nationwide study

被引：18

作者：

Loft, N. ^{[1
]}

Skov, L. ^{[1
]}

Bryld, L. E. ^{[2
]}

Gislason, G. ^{[3
]}

Egeberg, A. ^{[1
]}

机构：

[1] Univ Copenhagen, Dept Dermatol & Allergy, Herlev & Gentofte Hosp, Kildegardsvej 28, DK-2900 Hellerup, Denmark

[2] Roskilde Hosp, Dept Dermatol, Sygehusvej 5, DK-4000 Roskilde, Denmark

[3] Univ Copenhagen, Dept Cardiol, Herlev & Gentofte Hosp, Kildegardsvej 28, DK-2900 Hellerup, Denmark

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2017年 / 31卷 / 08期

关键词：

INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; CONTROLLED-TRIAL; DOUBLE-BLIND; PHASE-III; EFFICACY; REGISTRY; SAFETY; MULTICENTER; USTEKINUMAB;

D O I：

10.1111/jdv.14156

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100227 [皮肤病学];

摘要：

引用

页码：E362 / E363

页数：2

共 10 条

[1]

Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study [J].

Ahlehoff, Ole ;

Gislason, Gunnar H. ;

Jorgensen, Casper H. ;

Lindhardsen, Jesper ;

Charlot, Mette ;

Olesen, Jonas B. ;

Abildstrom, Steen Z. ;

Skov, Lone ;

Torp-Pedersen, Christian ;

Hansen, Peter Riis .

EUROPEAN HEART JOURNAL, 2012, 33 (16) :2054-2064

[2]

German psoriasis registry PsoBest: objectives, methodology and baseline data [J].

Augustin, Matthias ;

Spehr, Christina ;

Radtke, Marc A. ;

Boehncke, Wolf-Henning ;

Luger, Thomas ;

Mrowietz, Ulrich ;

Reusch, Michael ;

Stroemer, Klaus ;

Wozel, Gottfried ;

v. Kiedrowski, Ralph ;

Rustenbach, Stephan J. ;

Purwins, Sandra ;

Reich, Kristian .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 (01) :48-58

[3]

The Danish National Prescription Registry [J].

Kildemoes, Helle Wallach ;

Sorensen, Henrik Toft ;

Hallas, Jesper .

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2011, 39 :38-41

[4]

Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR) [J].

Kimball, A. B. ;

Leonardi, C. ;

Stahle, M. ;

Gulliver, W. ;

Chevrier, M. ;

Fakharzadeh, S. ;

Goyal, K. ;

Calabro, S. ;

Langholff, W. ;

Menter, A. .

BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) :137-147

[5]

Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4

[6]

The Danish National Patient Register [J].

Lynge, Elsebeth ;

Sandegaard, Jakob Lynge ;

Rebolj, Matejka .

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2011, 39 :30-33

[7]

A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction [J].

Papp, KA ;

Tyring, S ;

Lahfa, M ;

Prinz, J ;

Griffiths, CEM ;

Nakanishi, AM ;

Zitnik, R ;

van de Kerkhof, PCM .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (06) :1304-1312

[8]

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) [J].

Papp, Kim A. ;

Langley, Richard G. ;

Lebwohl, Mark ;

Krueger, Gerald G. ;

Szapary, Philippe ;

Yeilding, Newman ;

Guzzo, Cynthia ;

Hsu, Ming-Chun ;

Wang, Yuhua ;

Li, Shu ;

Dooley, Lisa T. ;

Reich, Kristian .

LANCET, 2008, 371 (9625) :1675-1684

[9]

Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence [J].

Parisi, Rosa ;

Symmons, Deborah P. M. ;

Griffiths, Christopher E. M. ;

Ashcroft, Darren M. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (02) :377-385

[10]

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial [J].

Reich, K ;

Nestle, FO ;

Papp, K ;

Ortonne, JP ;

Evans, R ;

Guzzo, C ;

Li, S ;

Dooley, LT ;

Griffiths, CEM .

LANCET, 2005, 366 (9494) :1367-1374

← 1 →